Skip to main content
INSMED Inc logo

INSMED Inc — Investor Relations & Filings

Ticker · INSM ISIN · US4576693075 LEI · 529900Q55QAG41CCAC11 US Manufacturing
Open in API
Filings indexed 1,323 across all filing types
Latest filing 2014-06-04 Director's Dealing
Country US United States of America
Listing US INSM

About INSMED Inc

https://insmed.com/

Insmed Incorporated is a global biopharmaceutical company dedicated to developing and commercializing therapies for patients with serious and rare diseases. The company's primary focus is on addressing areas of high unmet medical need. Its marketed product, Arikayce (liposomal amikacin for inhalation), is a treatment for Mycobacterium avium complex (MAC) lung disease. Insmed leverages proprietary technologies, such as its advanced liposomal pulmonary delivery system, to create novel treatments. The company maintains a diverse pipeline of investigational medicines and is actively advancing potential new therapies through various stages of clinical trials.

Recent filings

Filing Released Lang Actions
4 Filing
Director's Dealing
2014-06-04 English
4 Filing
Director's Dealing
2014-06-02 English
3 Filing
Director's Dealing
2014-06-02 English
S-3ASR Filing
Capital/Financing Update Classification · 95% confidence The document is a Form S-3 Registration Statement filed with the SEC by Insmed Incorporated. It includes a prospectus for the offering of common stock, describing the terms of the offering, risk factors, use of proceeds, and other related information. The document is a registration statement under the Securities Act of 1933, used for securities offerings and capital raising. It is not a financial report, earnings release, management discussion, or any other type of report. It is clearly a capital/financing update related to the registration and offering of securities. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content support a high confidence in this classification.
2014-05-30 English
8-K Filing
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes the appointment of a new director to the board and detailed voting results from the company's 2014 Annual Meeting of Shareholders. The document does not contain full financial statements or comprehensive financial performance data, so it is not an Annual Report (10-K) or Interim Report (IR). It also is not a proxy statement or solicitation material but reports on the results of shareholder votes and board changes. The key sections are Item 5.02 (Departure/Election of Directors) and Item 5.07 (Submission of Matters to a Vote of Security Holders). This matches the description of Board/Management Information (MANG) for director appointments and Declaration of Voting Results & Voting Rights Announcements (DVA) for voting results. Since the document contains both director appointment and voting results, the primary focus is on the voting results section which is more detailed and central to the filing. Therefore, the best classification is Declaration of Voting Results & Voting Rights Announcements (DVA). The document length (6466 characters) and detailed vote counts confirm it is not a brief announcement but a full voting results report.
2014-05-29 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text mentions a press release about clinical trial results, which is an event announcement rather than a full financial report or detailed filing. The document length is short (2794 characters), and it primarily serves to notify the market of a specific event (clinical trial results) rather than providing comprehensive financial data or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2014-05-20 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.